SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0250 7005 OR L773:1791 7530 ;srt2:(2010-2014)"

Sökning: L773:0250 7005 OR L773:1791 7530 > (2010-2014)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
41.
  • Lindgren, Theres, et al. (författare)
  • Alterations in Gene Expression During Radiation-Induced Mitotic Catastrophe in He La Hep2 Cells
  • 2014
  • Ingår i: Anticancer Research. - INT INST ANTICANCER RESEARCH. - 0250-7005 .- 1791-7530. ; 34:8, s. 3875-3880
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Aim: To explore kinetic changes in the gene expression profile during radiation-induced mitotic catastrophes. Materials and Methods: Gene expression changes were measured in HPV-infected HeLa Hep2 tumor cells following exposure to 5 Gy of ionizing radiation (Co-60). Signaling pathways were explored and correlated to the biological responses linked to mitotic catastrophe. Results: Following irradiation a transient G(2)-arrest was induced. Anaphase bridge formation and centrosome hyperamplification was observed. These phenotypical changes correlated well with the observed gene expression changes. Genes with altered expression were found to be involved in mitotic processes as well as G(2)- and spindle assembly checkpoints. Also centrosome-associated genes displayed an increased expression. Conclusion: This study elucidates specific characteristics in the altered gene expression pattern induced by irradiation, which can be correlated to the events of mitotic catastrophe in HeLa Hep2 cells. Therapeutic strategies modulating these alterations might potentiate future therapy and enhance tumor cell killing.</p>
  •  
42.
  • Lindquist, David, et al. (författare)
  • Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer
  • 2012
  • Ingår i: Anticancer Research. - 0250-7005 .- 1791-7530. ; 32:1, s. 153-161
  • Tidskriftsartikel (refereegranskat)abstract
    • <p><strong>BACKGROUND:</strong> Patients with tonsillar and base of tongue cancer, which are human papillomavirus (HPV) positive, have a better clinical outcome than those with HPV-negative tumors. The identification of additional predictive markers for response to therapy could still be of great use.</p> <p><strong>MATERIALS AND METHODS:</strong> Tumor markers CD44, p16, epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), E-cadherin, cyclooxygenase-2 (COX 2), Ki-67, and p27 were analyzed by immunochemistry, and HPV status was tested by polymerase chain reaction (PCR) in tumors from 73 patients and correlated to survival.</p> <p><strong>RESULTS:</strong> High intensity CD44 staining (p=0.006) and high EGFR expression (p=0.026) were indicators of poor prognosis, while high p16 expression (p=0.021) and younger age (p=0.002) were positive prognostic markers for disease-specific survival. Furthermore, staining of CD44 (p=0.026) and age (p=0.002) were shown to be strong prognostic markers in multivariate analysis, which should be evaluated further for possible use in clinical practice.</p>
  •  
43.
  • Lunde, Mai Lill Suhr, et al. (författare)
  • Gene expression analysis by cDNA microarray in oral cancers from two Western populations
  • 2010
  • Ingår i: Anticancer Research. - 0250-7005 .- 1791-7530. ; 30:4, s. 1083-1091
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>BACKGROUND: In this work, gene expression profile was examined in 19 cases of oral cancer (OC) obtained from patients from Sweden (n=8) and UK (n=11) and the findings were tested for correlation to patient's clinicopathological data. MATERIALS AND METHODS: Following total RNA extraction, cDNA synthesis, labeling with fluorescent dyes and hybridization to the 21 k human oligonucleotide microarrays, slides were scanned and images were subjected to Genepix and J-Express analysis. Results for selected genes were validated by quantitative reverse transcriptase polymerase chain reaction (Q-RT-PCR). RESULTS: 42 genes were identified as being differentially expressed. These included 39 genes of known functions (such as fatty acid synthase (FASN), 5' nucleotidase, ecto (NT5E), high mobility group AT-hook (HMGA1), and v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS)) and 3 novel genes; 26 (67%) of the 39 genes with known functions were previously reported in oral/head and neck tumors examined from other populations. Hierarchical clustering of the samples using the 42 genes demonstrated that samples mainly clustered in the same population. CONCLUSION: These results illustrate that microarrays can be used to identify distinct patterns of gene expression in different populations, but with no direct association to clinicopathological parameters. The fact that 67% of the 39 genes with known functions found in this work were previously reported in oral/head and neck tumors from other populations provides clear evidence that development of these tumors follows the same biological pathways irrespective of the source of the samples used.</p>
  •  
44.
  • Miftakhova, Regina, et al. (författare)
  • DNA Methylation in ATRA-treated leukemia cell lines lacking a PML-RAR chromosome translocation
  • 2012
  • Ingår i: Anticancer Research. - International Institute of Anticancer Research. - 0250-7005 .- 1791-7530. ; 32:11, s. 4715-4722
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Abstract A deficient retinoic acid signaling has been suggested to be an important cause of the clinical inefficacy of all-trans retinoic acid (ATRA) therapy in non-promyelocytic (non-PML) forms of acute myeloid leukemia (AML). The general aim of the present work was to explore novel ways to take advantage of the anti-leukemic potential of ATRA, and, specifically, to search for a synergism between ATRA and epigenetic drugs. Because previous reports have found no major influence of ATRA on DNA methylation, we investigated whether ATRA-mediated differentiation of the U937 and HL-60 AML cell lines, both lacking a PML-retinoic acid receptor (RAR) fusion product, is accompanied by early-appearing and weak changes in CpG methylation. We report that in HL-60 cells, by using a highly quantitative analysis of a set of genes found to be abnormally expressed in AML, polymerase chain reaction (PCR)-amplified p16 gene promoter molecules (each with 15 CpG sites), exhibited a CpG methylation level of 0-4% in untreated cells, which increased to 4-21% after treatment with ATRA for seven days. In contrast to HL-60 cells, U937 cells exhibited a very high CpG methylation level in p16, and ATRA did not influence the promoter methylation of this gene. In the total CCGG sites of the genome, analysed using a methylation-sensitive restriction enzyme, CpG methylation was significantly lower in ATRA-treated HL-60 (p<0.01) and U937 cells (p<0.05) than in controls. Taken together, our findings show that ATRA can influence DNA methylation, and suggest that future research should investigate whether epigenetic modulation may evoke a clinical effect of ATRA in leukemia.</p>
  •  
45.
  • Mohanty, Chitralekha, et al. (författare)
  • Predicting the sensitivity to ion therapy based on the response to photon irradiation - experimental evidence and mathematical modelling
  • 2014
  • Ingår i: Anticancer Research. - 0250-7005 .- 1791-7530. ; 34:6, s. 2801-2806
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background/Aim: The use of ion radiation therapy is growing due to the continuously increasing positive clinical experience obtained. Therefore, there is a high interest in radio-biological experiments comparing the relative efficiency in cell killing of ions and photons as the photons are currently the main radiation modality used for cancer treatment. This comparison is particularly important since the treatment planning systems (TPSs) used at the main ion therapy centres make use of parameters describing the cellular response to photons, respectively ions, determined in vitro. It was therefore the aim of this paper to compare the effects of high LET ion radiation with low LET photons and determine whether the cellular response to low LET could predict the response to high LET irradiation. Materials and Methods: Clonogenic cell survival data of five tumor cell lines irradiated with different ion beams of similar, clinically-relevant, LET were studied in relation to the response to low LET photons. Two mathematical models were used to fit the data, the repairable-conditionally repairable damage (RCR) model and the linear quadratic (LQ) model. Results: The results indicate that the relative biological efficiency of the high LET radiation assessed with the RCR model could be predicted based only on the response to the low LET irradiation. Conclusion: The particular features of the RCR model indicate thus that tumor cells showing a large capacity for repairing the damage will have the larger benefit from radiation therapy with ions beams.</p>
  •  
46.
  • Månsson, Christopher, et al. (författare)
  • Safety and Preliminary Efficacy of Ultrasound-guided Percutaneous Irreversible Electroporation for Treatment of Localized Pancreatic Cancer
  • 2014
  • Ingår i: Anticancer Research. - 0250-7005 .- 1791-7530. ; 34:1A, s. 289-293
  • Tidskriftsartikel (refereegranskat)abstract
    • <p><strong>Background:</strong></p><p>Irreversible electroporation (IRE) is a local tumor treatment. Thin needles are placed percutaneously around the tumor under ultrasound guidance. Short pulses of direct current sent through the tissue irreversibly increase cell membrane permeability leading to cell death. We report a phase I study assessing the safety of ultrasound guided percutaneous IRE in patients with localized pancreatic cancer (LPC).</p><p><strong>Patients and Methods:</strong></p><p>Five patients (three males) with LPC, judged unsuitable for surgery, chemotherapy, or non-resectable after standard oncological treatment, were treated with IRE. The treatment was given under general anesthesia with muscle relaxation.</p><p><strong>Results:</strong></p><p>No serious treatment-related adverse events were observed. There was no 30-day mortality. One patient went on to laparotomy and had a R0 pancreaticoduodenectomy with portal vein resection. Six months after the treatment, two patients had no signs of recurrence on computed tomography or contrast-enhanced ultrasound.</p><p><strong>Conclusion: </strong></p><p>IRE for LPC can be safely performed percutaneously under ultrasound guidance, with promising initial results regarding efficacy.</p>
  •  
47.
  •  
48.
  • Norberg, Maria, et al. (författare)
  • Screening for Cytotoxic Compounds in Poor-prognostic Chronic Lymphocytic Leukemia
  • 2012
  • Ingår i: Anticancer Research. - 0250-7005 .- 1791-7530. ; 32:8, s. 3125-3136
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background/Aim: For chronic lymphocytic leukemia (CLL) patients with poor-prognostic genomic aberrations the therapeutic options are limited. We used the Spectrum Collection library to identify compounds with anti-leukemia activity in high-risk CLL.</p><p>Materials and Methods: We identified substances with equal high cytotoxic activity in vitro in samples from poor-prognostic CLL (11q-/17p-, n=3) as compared to those from favourable-prognostic CLL (13q-, n=3). Cell survival was measured by fluorometric microculture cytotoxicity assay.</p><p>Results: Out of 2,000 compounds, 65 had a similar effect in both prognostic groups. Fifteen compounds were selected for dose-response experiments in 16 additional CLL samples. Of these compounds, 12 continued to have similar cytotoxicity between prognostic subgroups. Additional experiments demonstrated that in CLL cells with 11q or 17p deletion, 5-azacytidine induced apoptosis in a dose-dependent manner and lipoprotein lipase expression was reduced following orlistat treatment.</p><p>Conclusion: Using primary cultures of cells from high-risk CLL patients for compound screening is a feasible approach and that 5-azacytidine and orlistat exemplify substances that exhibit cytotoxicity in poor-risk CLL.</p>
  •  
49.
  • Nyström, Hanna, 1980-, et al. (författare)
  • Liver-metastatic potential of colorectal cancer is related to the stromal composition of the tumour
  • 2012
  • Ingår i: Anticancer Research. - 0250-7005 .- 1791-7530. ; 32:12, s. 5183-5191
  • Tidskriftsartikel (refereegranskat)abstract
    • <p><strong>Background</strong>: The tumour stroma is an important modulator of cancer cell behaviour. The aim of this study was to compare the stromal composition between primary colorectal cancer (CRC) and colorectal liver metastases (CLM).</p><p><strong>Materials and Methods</strong>: The stromal composition in matched tissue sections of CRC and subsequent CLM was analysed, and related to clinical parameters.</p><p><strong>Results</strong>: Differences in the expression pattern of type I collagen and type IV collagen in CRC was related to a higher risk of CLM. Two types of CLM the desmoplastic and pushing type were identified. The time between CRC and diagnosis of CLM was shorter (p=0.047) for desmoplastic CLM. The mortality rate was higher for pushing CLM due to frequent extrahepatic disseminated disease. A difference in the overall survival rate between patients with desmoplastic and those with pushing CLM was seen at follow-up of more than 60 months (p=0.046).</p><p><strong>Conclusion</strong>: The liver-metastasizing potential is related to the stromal composition of primary CRC. There are distinct growth patterns in CLM with differences in stromal composition and clinical outcome.</p>
  •  
50.
  • Papworth, Karin, 1964-, et al. (författare)
  • Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma
  • 2010
  • Ingår i: Anticancer Research. - International Institute of Anticancer Research. - 0250-7005 .- 1791-7530. ; 30:7, s. 2953-2957
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>The aim of this study was to evaluate the prognostic information of soluble carbonic anhydrase (CA) IX expression in renal cell carcinoma (RCC).</p><p>PATIENTS AND METHODS: Serum CA IX was analysed in 361 patients. Tumour type, TNM stage, nuclear grade, and RCC-specific survival were assessed. Serum and immunohistochemical expression were compared.</p><p>RESULTS: Median serum CA IX expression was 141 (range 2-4, 181) pg/ml. Levels were significantly higher in 287 patients with clear cell, compared to 40 papillary (p&lt;0.001) and 22 oncocytoma (p=0.002), but not to 12 chromophobe RCC (p=0.35). Serum CA IX in clear cell RCC was positively correlated to TNM stage (p=0.002). There was a positive trend between serum and immunohistochemical CA IX expression. In a multivariate analysis of clear cell RCC, TNM stage and nuclear grade were independent prognostic factors.</p><p>CONCLUSION: Serum CA IX was higher in clear cell RCC compared to other RCC types. In clear cell RCC, serum CA IX correlated to TNM stage, but not survival.</p>
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (3)
Typ av publikation
tidskriftsartikel (140)
forskningsöversikt (6)
konferensbidrag (3)
Typ av innehåll
refereegranskat (141)
övrigt vetenskapligt (9)
Författare/redaktör
Rubio, CA, (19)
Dalianis, T, (9)
Henriksson, Roger, (8)
Bergqvist, Michael, (7)
Ramqvist, T, (7)
Sand, Lars, (7)
visa fler...
Ekman, Simon (6)
Willén, Roger, (6)
Nygren, Peter, (5)
Derwinger, Kristoffe ... (5)
Brodin, Ola, (5)
Bergström, Stefan (5)
Ekberg, Lars (4)
Janson, Christer, (4)
Friesland, Signe (4)
Sandelin, Martin, (4)
Befrits, R., (4)
Ranstam, Jonas, (4)
Xu, Ning, (4)
Dasu, Alexandru (4)
Persson, Jenny L., (4)
Lindahl, Bengt, (4)
Nyman, Jan (4)
Holgersson, Georg, (4)
Sorbe, Bengt, (4)
Holgersson, Margaret ... (4)
Helsing, Martin, (4)
Nesi, G (4)
Jalouli, Jamshid (4)
Jalouli, Miranda M., (4)
Andersson, Roland, (3)
Bergqvist, M. (3)
Hellberg, Dan, (3)
Matussek, Andreas, (3)
Ansari, Daniel, (3)
Löfgren, Sture, (3)
Sun, Xiao-Feng (3)
Toma-Dasu, Iuliana, (3)
Skarstedt, Marita, (3)
Nasman, A, (3)
Brodin, O, (3)
Kodeda, Karl, (3)
Nordfors, C, (3)
Ewers, Sven-Börje, (3)
Luo, Guanghua (3)
Zheng, Lu (3)
Dimberg, Jan, (3)
Zar, Niklas, (3)
Tot, Tibor, (3)
Lamberg Lundström, K ... (3)
visa färre...
Lärosäte
Karolinska Institutet (50)
Uppsala universitet (29)
Lunds universitet (23)
Umeå universitet (14)
Göteborgs universitet (12)
Linköpings universitet (8)
visa fler...
Örebro universitet (5)
Högskolan i Jönköping (3)
Stockholms universitet (2)
Sveriges Lantbruksuniversitet (2)
Kungliga Tekniska Högskolan (1)
swepub_uni:mau_t (1)
Högskolan i Skövde (1)
visa färre...
Språk
Engelska (149)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (100)
Naturvetenskap (1)
Lantbruksvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy